The
global Sclerotherapy
Market is anticipated to grow at a higher CAGR in the forthcoming
period. The primary objective of sclerotherapy is to trigger endothelial and
vein wall injury in controlled environment. The resultant is elimination of
abnormal vessels that transport retrograde flow without disturbing surrounding
vessels that carry normal flow. In such cases, scelosant effect results in a
fibrous cord that gets absorbed over time. Therefore, sclerotherapy is used in
treatment of all types and dimensions of varicosities.
The
therapy is considered as a standard treatment for reticular veins, leg
telangiectasias and venulectasias. Sclerotherapy has been standardly used for
major varicosities coupled with direct injection into saphenous vein at the
saphenofemoral intersection. Therefore, on a commercial level, sclerotherapy is
used extensively in treatment of valvular inadequacy of varicose veins.
Driving
factors responsible for the growth of sclerotherapy market includes rising
incidences of varicose veins and vein surgeries. Other factors such as rise in
medical infrastructure, availability of large consumer pool in developed and
emerging economies, sedentary lifestyle, rising prevalence of leg casualties
stimulate the growth of the industry.
Segmentation
based on type, the sclerotherapy market includes detergents, chemical irritants
and osmotic agents. Segmentation based on application, the sclerotherapy
industry includes hospitals & clinics. Geographically, sclerotherapy market
spans North America, South America, Europe, Asia-Pacific, Middle-East and
Africa. APAC and MEA market is anticipated to grow at a positive CAGR in the
forthcoming period due to rising incidences of varicose veins. Also, growing
need for sclerotherapy diagnosis is likely to contribute to these market.
Europe and North America market is anticipated to grow at a higher CAGR in the
forthcoming period owing to rising incidences of leg injuries, varicose veins
and reticular veins.
Market Segment:
This report studies the global
Sclerotherapy market, analyzes and researches the Sclerotherapy development
status and forecast in United States, EU, Japan, China, India and Southeast
Asia. This report focuses on the top players in global market, like
•
BTG
•
Kreussler.
•
LGM Pharma
•
Troikaa
•
Changan Tianyu group
•
Bioniche Pharma Group Ltd
•
Omega Pharmaceuticals
•
Angiodynamics
•
ENDO-FLEX
•
MTW ENDOSKOPIE
Market segment by Regions/Countries,
this report covers
•
United States
•
EU
•
Japan
•
China
•
India
•
Southeast Asia
Market segment by Type, Sclerotherapy
can be split into
•
Detergents
•
Osmotic Agents
•
Chemical Irritants
Market segment by Application,
Sclerotherapy can be split into
•
Hospital
•
Clinic
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/sclerotherapy-market/request-sample
No comments:
Post a Comment